Real-Life Effectiveness of Vismodegib in Patients with Metastatic and Advanced Basal Cell Carcinoma: Characterization of Adverse Events and Assessment of Health-Related Quality of Life using the Dermatology Life Quality Index (DLQI) Test

INTRODUCTION: Non-melanoma skin cancer (NMSC) is the most common type of human tumor, with an estimated five million new cases each year. NMSC has been described as having a major impact on the health-related quality of life of the patient. Vismodegib is a hedgehog pathway inhibitor therapy for pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Villani, Alessia, Fabbrocini, Gabriella, Cappello, Milena, Costa, Claudia, Scalvenzi, Massimiliano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704212/
https://www.ncbi.nlm.nih.gov/pubmed/31165365
http://dx.doi.org/10.1007/s13555-019-0303-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704212/
https://www.ncbi.nlm.nih.gov/pubmed/31165365
http://dx.doi.org/10.1007/s13555-019-0303-4

Ejemplares similares